Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1beta and anti-erbB2: potential mechanism for trastuzumab-induced cardiotoxicity

Circulation
Douglas B SawyerThomas M Suter

Abstract

There is an increased incidence of heart failure in patients treated concurrently with anthracyclines and the chemotherapeutic anti-erbB2 agent trastuzumab (Herceptin). On the basis of our previous studies with recombinant neuregulin-1beta (NRG-1beta), a ligand for the erbB2 receptor tyrosine kinase, we hypothesized that activation of erbB2 by anti-erbB2 versus NRG-1 would cause differential effects on myocyte intracellular signaling as well as anthracycline-induced myofibrillar injury and might potentially account for the clinical toxicity of trastuzumab in the setting of concurrent anthracycline therapy. We tested this hypothesis using adult rat ventricular myocytes (ARVMs) in culture, assessing myofibrillar structure by immunostaining for myomesin and filamentous actin. Activation of erbB2, extracellular signal-regulated kinase 1/2 (Erk1/2), and Akt was assessed by use of antibodies to phosphorylated activated receptor or kinase detected by immunoblot. ARVMs treated with doxorubicin (0.1 to 0.5 micromol/L) showed a concentration-dependent increase in myofilament disarray. NRG-1beta (10 ng/mL) activated erbB2, Erk1/2, and Akt in ARVMs and significantly reduced anthracycline-induced disarray. In contrast to NRG-1beta, anti-erb...Continue Reading

References

Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·Y Yarden
Jun 1, 1990·Developmental Biology·M Eppenberger-EberhardtH M Eppenberger
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·H ItoF M Torti
Feb 1, 1984·The Journal of Cell Biology·B K GroveH M Eppenberger
Oct 1, 1981·American Heart Journal·M R BristowJ R Daniels
Nov 23, 1995·Nature·D Meyer, C Birchmeier
Mar 29, 2001·Journal of Molecular and Cellular Cardiology·L XiaoW S Colucci

❮ Previous
Next ❯

Citations

Jan 18, 2012·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Stefan A LangeJens Jung
Apr 24, 2009·Breast Cancer Research and Treatment·Luca Gianni
Jul 4, 2012·Current Heart Failure Reports·Carrie GeisbergDouglas B Sawyer
Jul 27, 2007·Cardiovascular Toxicology·Billy ChenDouglas B Sawyer
Jul 27, 2007·Cardiovascular Toxicology·Christian ZuppingerThomas M Suter
Jun 5, 2004·The Breast : Official Journal of the European Society of Mastology·T M SuterC Barton
Dec 5, 2003·Journal of Molecular and Cellular Cardiology·Ryuji FukazawaDouglas B Sawyer
Mar 22, 2003·Experimental Cell Research·Douglas L Falls
Feb 15, 2003·Trends in Cardiovascular Medicine·Alistair N GarrattCarmen Birchmeier
Jul 25, 2006·Nature Medicine·Risto KerkeläThomas Force
Jun 15, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D LenihanJ Baselga
Jul 14, 2012·European Heart Journal·Thomas M Suter, Michael S Ewer
Dec 17, 2009·Journal of the National Cancer Institute·Adriana AlbiniDouglas M Noonan
Apr 14, 2010·Journal of Cardiovascular Pharmacology·Christian Zuppinger, Thomas M Suter
Mar 23, 2013·Journal of Cardiovascular Pharmacology·Tao AnJian Zhang
Jan 28, 2004·Annual Review of Pharmacology and Toxicology·Thomas Holbro, Nancy E Hynes
Mar 20, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Brian Wadugu, Bernhard Kühn
Oct 6, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Yun BianXinhua Yan
Jan 16, 2013·Chemotherapy Research and Practice·Zahi MitriRuth O'Regan
Jan 1, 2008·Breast Care·Dimitrios ChatsiproiosThomas Suter
Oct 30, 2012·Circulation Research·Oghenerukevwe OdieteDouglas B Sawyer
Jul 15, 2006·Breast Cancer Research : BCR·Thea PugatschRonen Beeri
Jun 17, 2003·Biological & Pharmaceutical Bulletin·Yuji YoshiyamaMotoko Kanke
May 3, 2008·Biological & Pharmaceutical Bulletin·Kwang-Hyun ParkDong-Hwan Sohn
Apr 16, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Margarita CalvoDavid L H Bennett
Jun 26, 2010·The Oncologist·Filippo MontemurroMassimo Aglietta
Jul 11, 2006·International Journal of Environmental Research and Public Health·Waneene C DorseyByron D Ford
Jan 26, 2012·International Journal of Medical Sciences·Manuel ValdiviesoLaurence H Baker
Feb 19, 2014·Journal of Cardiovascular Medicine·Giulia RussoUNKNOWN ICARO (Italian CARdio-Oncological) Network
Nov 16, 2013·Current Heart Failure Reports·Cristi L GalindoDouglas B Sawyer
Apr 1, 2014·Current Heart Failure Reports·Carrie Geisberg Lenneman
Jan 31, 2014·Cardiovascular Research·Emily M Parodi, Bernhard Kuhn
May 7, 2009·Targeted Oncology·Evandro de AzambujaMartine Piccart-Gebhart

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.